Search results
Fred L. Goldenberg: Medicare 2025 starting to bloom
Traverse City Record-Eagle· 1 hour agoOver the last few weeks, I’ve been involved in several meetings, both in-person and online, regarding anticipated changes to Medicare and supplemental programs for 2025. According to the American ...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 5 days agoTrulicity, another diabetes treatment, had $1.46 billion in first-quarter sales, down 26% and below...
Eli Lilly's Weight-Loss Drug Still Going Strong, Boosts Annual Forecast
Benzinga via AOL· 5 days agoThe volume increase was primarily driven by growth from Mounjaro, Zepbound, Verzenio, and Jardiance,...
Unpacking the Latest Options Trading Trends in Eli Lilly and Co - Eli Lilly and Co (NYSE:LLY)
Benzinga· 3 days agoLilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. Current ...
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Zacks via Yahoo Finance· 5 days agoEli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises...
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 5 days agoThe financial overview indicates that LLY has experienced revenue growth driven by increased volume...
IBD Stock Of The Day Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views
Investor's Business Daily· 5 days agoHe kept his in-line (neutral) rating on Eli Lilly stock. Sales of other key products, cancer drug...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 2 days agoLilly’s first-quarter results were soft as it beat estimates for earnings but missed the same for...
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
Zacks via Yahoo Finance· 4 days agoEli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity...
Eli Lilly and Co (LLY) Surpasses Q1 Earnings Estimates and Raises Full-Year Guidance
GuruFocus.com via Yahoo Finance· 5 days agoThis growth was primarily fueled by strong sales from its key products like Mounjaro, Zepbound,...